OVERVIEW

Virtual European Atherosclerosis Society (EAS) Congress 2021 is organized by European Atherosclerosis Society (EAS), Kenes Group and will be held from May 30 - Jun 02, 2021.

Description:
During the meeting they will explore the latest developments in research into the causes of atherosclerosis and related vascular disease, and how these may affect the clinical guidelines for diagnosis and treatment. One of the features of EAS Congress is the high-level interdisciplinary exchange between clinicians and basic researchers. With many world-leading experts already confirmed, the EAS 2021 scientific programme will offer a bench-to-bedside overview of the latest current research in the field - including the award-winning Anitschkow Lecture, outstanding Keynote Lectures, state-of-the-art Plenary Sessions, and focused Workshops and Advance Clinical Seminars. They firmly believe that presenting and discussing one’s work with others and sparking ideas from others’ work is the key to progress in science. They encourage you to join us – to ask questions and share ideas during the Science at a Glance and Poster Sessions.

Workshops:
Monday 31 May:
• Lipid metabolism and atherothrombosis
• Influence of genes on the susceptibility to atherosclerosis
• Current insights into the role of gut microbiota in atherosclerosis
• Macrophage function and impaired resolution of inflammation in atherosclerosis
• Novel approaches and future targets to lower circulating triglycerides

Tuesday 01 June:
• Immunopathological responses elicited by lipoprotein retention in the arterial wall
• Liver as the center of lipid metabolism
• Diet and CVD
• Cell metabolism and vascular health
• Lymphatics, lipoproteins and the endothelium
• Aortic valve stenosis and Lp(a): from genetics to physiopathology

Wednesday 02 June:
• Extracellular matrix components: guardians of vascular health
• Lifestyle and prevention: Secrets to success
• Atherosclerosis in ageing societies
• Imaging and the vulnerable plaque

Scientific Topics:
• Pathogenesis of Atherosclerosis
• Lipids and Lipoproteins
• Dyslipidemia and Risk Factors
• Clinical Vascular Disease

Additional details will be posted as soon as information is available.